{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:16:44Z","timestamp":1770509804525,"version":"3.49.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T00:00:00Z","timestamp":1331078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033345","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T22:00:27Z","timestamp":1331157627000},"page":"e33345","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Homocysteine, Grey Matter and Cognitive Function in Adults with Cardiovascular Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Andrew H.","family":"Ford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griselda J.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola T.","family":"Lautenschlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Arnolda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Flicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo P.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10545-010-9177-4","article-title":"Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.","volume":"34","author":"HJ Blom","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10545-010-9235-y","article-title":"Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.","volume":"34","author":"R Clarke","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer&apos;s disease.","volume":"346","author":"S Seshadri","year":"2002","journal-title":"N Engl J Med"},{"key":"ref4","article-title":"Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study.","author":"AH Ford","year":"2011","journal-title":"Mol Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.autrev.2009.08.004","article-title":"Homocysteine and Raynaud&apos;s phenomenon: a review.","volume":"9","author":"PE Lazzerini","year":"2010","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00774-010-0191-2","article-title":"Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment.","volume":"29","author":"M Shiraki","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejheart.2005.11.016","article-title":"A review of homocysteine and heart failure.","volume":"8","author":"M Herrmann","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archpsyc.65.11.1286","article-title":"Homocysteine and depression in later life.","volume":"65","author":"OP Almeida","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"ref9","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.","volume":"56","author":"KS McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.","volume":"325","author":"DS Wald","year":"2002","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.","volume":"274","author":"CJ Boushey","year":"1995","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.289.10.1251","article-title":"Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction.","volume":"289","author":"RS Vasan","year":"2003","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1177\/15648265080292S119","article-title":"The worldwide challenge of the dementias: a role for B vitamins and homocysteine?","volume":"29","author":"AD Smith","year":"2008","journal-title":"Food Nutr Bull"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjmed.2010.01.017","article-title":"Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials.","volume":"123","author":"DS Wald","year":"2010","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/WNL.58.10.1539","article-title":"Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.","volume":"58","author":"PS Sachdev","year":"2002","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10111","article-title":"Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.","volume":"51","author":"SE Vermeer","year":"2002","journal-title":"Ann Neurol"},{"key":"ref18","first-page":"137","article-title":"Risk factors for vascular dementia: a review.","volume":"5","author":"I Skoog","year":"1994","journal-title":"Dementia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.pnpbp.2005.06.026","article-title":"Homocysteine and brain atrophy.","volume":"29","author":"PS Sachdev","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref20","article-title":"Two-year course of cognitive function and mood in adults with congestive heart failure and coronary artery disease: the Heart-Mind Study.","author":"OP Almeida","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"ref21","first-page":"189","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"AS Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/gps.886","article-title":"Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample.","volume":"18","author":"JG Williams","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/0022-006X.56.1.123","article-title":"Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test.","volume":"56","author":"DC Delis","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"ref25","article-title":"Wechsler Adult Intelligence Scale III.","author":"D Wechsler","year":"1997","journal-title":"Psychological Corporation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","article-title":"Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection.","volume":"422","author":"A Araki","year":"1987","journal-title":"J Chromatogr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about total homocysteine determinations: an expert opinion.","volume":"50","author":"H Refsum","year":"2004","journal-title":"Clin Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).","volume":"29","author":"K Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"ref29","article-title":"The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and blood vessels","year":"1964"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/europace\/euq163","article-title":"Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment.","volume":"12","author":"MA Castel","year":"2010","journal-title":"Europace"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1467-842X.2001.tb00326.x","article-title":"Developing national physical activity guidelines for Australians.","volume":"25","author":"G Egger","year":"2001","journal-title":"Aust N Z J Public Health"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1022329317218","article-title":"Homocysteine-evoked 45Ca release in the rabbit hippocampus is mediated by both NMDA and group I metabotropic glutamate receptors: in vivo microdialysis study.","volume":"28","author":"JW Lazarewicz","year":"2003","journal-title":"Neurochem Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0014-5793(00)01278-3","article-title":"Homocysteine accelerates endothelial cell senescence.","volume":"470","author":"D Xu","year":"2000","journal-title":"FEBS Lett"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(02)02702-3","article-title":"Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer&apos;s Disease.","volume":"518","author":"SB Vafai","year":"2002","journal-title":"FEBS Lett"},{"key":"ref35","first-page":"81","article-title":"Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer&apos;s disease: a volumetric magnetic resonance imaging study.","volume":"10","author":"AL Foundas","year":"1997","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/174182670100800605","article-title":"Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.","volume":"8","author":"R Clarke","year":"2001","journal-title":"J Cardiovasc Risk"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1385-299X(02)00202-7","article-title":"Volume estimation of prefrontal cortical subfields using MRI and stereology.","volume":"10","author":"MA Howard","year":"2003","journal-title":"Brain Res Brain Res Protoc"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archgenpsychiatry.2011.28","article-title":"Excess significance bias in the literature on brain volume abnormalities.","volume":"68","author":"JP Ioannidis","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1017\/S1041610210000499","article-title":"Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension.","volume":"22","author":"MJ Firbank","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly.","volume":"126","author":"T den Heijer","year":"2003","journal-title":"Brain"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.","volume":"5","author":"AD Smith","year":"2010","journal-title":"PLoS One"},{"key":"ref42","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.","author":"CA de Jager","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction.","volume":"354","author":"KH Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer&apos;s disease prevalence.","volume":"10","author":"DE Barnes","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(10)70187-3","article-title":"B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.","volume":"9","year":"2010","journal-title":"Lancet Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T06:36:23Z","timestamp":1540362983000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033345"}},"subtitle":[],"editor":[{"given":"Jerson","family":"Laks","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,7]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033345","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,7]]}}}